PetMed Deferred Long Term Liab from 2010 to 2024
| PETS Stock | USD 4.63 0.07 1.49% |
Deferred Long Term Liabilities | First Reported 2011-06-30 | Previous Quarter 1.1 M | Current Value 1.3 M | Quarterly Volatility 486.8 K |
Check PetMed Express financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among PetMed Express' main balance sheet or income statement drivers, such as Depreciation And Amortization of 7.4 M, Interest Expense of 3.6 M or Selling General Administrative of 58 M, as well as many indicators such as Price To Sales Ratio of 0.32, Dividend Yield of 0.14 or PTB Ratio of 0.94. PetMed financial statements analysis is a perfect complement when working with PetMed Express Valuation or Volatility modules.
PetMed | Deferred Long Term Liab |
Latest PetMed Express' Deferred Long Term Liab Growth Pattern
Below is the plot of the Deferred Long Term Liab of PetMed Express over the last few years. It is liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue. PetMed Express' Deferred Long Term Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in PetMed Express' overall financial position and show how it may be relating to other accounts over time.
| Deferred Long Term Liab | 10 Years Trend |
|
Deferred Long Term Liab |
| Timeline |
PetMed Deferred Long Term Liab Regression Statistics
| Arithmetic Mean | 639,518 | |
| Geometric Mean | 0.00 | |
| Coefficient Of Variation | 74.78 | |
| Mean Deviation | 434,617 | |
| Median | 970,000 | |
| Standard Deviation | 478,243 | |
| Sample Variance | 228.7B | |
| Range | 1.2M | |
| R-Value | 0.70 | |
| Mean Square Error | 125.1B | |
| R-Squared | 0.49 | |
| Significance | 0 | |
| Slope | 75,032 | |
| Total Sum of Squares | 3.2T |
PetMed Deferred Long Term Liab History
About PetMed Express Financial Statements
PetMed Express shareholders use historical fundamental indicators, such as Deferred Long Term Liab, to determine how well the company is positioned to perform in the future. Although PetMed Express investors may analyze each financial statement separately, they are all interrelated. The changes in PetMed Express' assets and liabilities, for example, are also reflected in the revenues and expenses on on PetMed Express' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Deferred Long Term Liabilities | 1.1 M | 1.2 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for PetMed Stock Analysis
When running PetMed Express' price analysis, check to measure PetMed Express' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PetMed Express is operating at the current time. Most of PetMed Express' value examination focuses on studying past and present price action to predict the probability of PetMed Express' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PetMed Express' price. Additionally, you may evaluate how the addition of PetMed Express to your portfolios can decrease your overall portfolio volatility.